The Medicines Company announced last week that its Angiomax patent has been upheld – an 'important court decision' which affirms that working with CMOs won’t invalidate a company's patent.
The EMA is recommending the suspension of several medicines after inspections revealed flawed studies at the India-based contract research organization (CRO), Semler Research Centre.
API and drug maker Patheon will begin trading on the New York Stock Exchange under the symbol PTHN later today.
Pharmaceutical Product Development (PPD) has won the 2016 OpenText Elite Award for the Most Innovative Project in the Health Sciences Sector.
Mitsubishi Tanabe has joined the Simcyp Consortium – gaining a license to the modeling and simulation group’s pharmacokinetic prediction technology.
Johnson Matthey said a slight decrease in API sales during the first quarter of its fiscal year was due to the timing of customer orders.
The end-to-end reimbursement tool from Medidata uses clinical trial data to calculate costs and make payments to investigative sites in real time, all in the cloud.
Exco InTouch has completed a HIPAA Privacy audit as the company continues to prepare for impending data protection regulations.
Content Provided by World Courier
In globalising the pharmaceutical industry oversight and control has increasingly become a challenge in managing product quality, consumer safety and organisational risk.